Additionally, splenic-derived B cells isolated from tumor-bearing mice polarized macrophages to a Th2 phenotype and a Bruton's tyrosine kinase (BTK) inhibitor, which targets B cells and myeloid cells, demonstrated reduced tumor growth in the orthotopic model (27). Here, BTK is linked to neoplasm.